The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Share News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 452.50
Bid: 445.00
Ask: 460.00
Change: 5.00 (1.12%)
Spread: 15.00 (3.371%)
Open: 447.50
High: 452.50
Low: 447.50
Prev. Close: 447.50
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Tristel's Hospital Surface Disinfection Focus Helps It Weather Virus

Mon, 19th Oct 2020 11:16

(Alliance News) - Infection prevention products provider Tristel PLC on Monday said annual profit grew as hospital surface disinfectant sales helped to offset a decline in medical device decontamination sales.

Revenue for the financial year ended June 30 was GBP31.7 million, up 21% from GBP26.2 million the year before. Pretax profit rose 40% to GBP6.6 million from GBP4.7 million.

"We delivered another very sound performance in a year turned on its head by Covid-19, the impact of which was a reduction of GBP0.5 million in medical device decontamination sales and an increase of GBP2 million in hospital surface disinfectant sales," said Chief Executive Paul Swinney.

During the March to June period, when the impact of Covid-19 was at its greatest, global sales were GBP11.8 million compared to GBP9.1 million in the same period last year, an increase of 30%. Medical device decontamination product sales accounted for 74% of sales in this period, while sales of hospital surface disinfection products accounted for 15%.

Tristel said it was able to steer its way through the early Covid-19 crisis by mitigating the fall in demand for its primary product portfolio via a rapid increase in supply of its hospital surface disinfection products.

Turning to the recently-started financial year, Swinney said the company has seen a "gradual recovery" in demand for medical device products in all its markets in the first quarter.

"Since February, we have acquired a significant number of hospital customers for our surface disinfectant products. We expect this build-up of our hospital surface disinfection business to continue throughout this and future years. It is a key strategic focus of the company," he added.

While further Covid-19 lockdowns may "temporarily interrupt our group's forward momentum", Tristel is optimistic for the year's trading outlook.

Tristel raised its full-year dividend by 12% to 6.18 pence.

Shares in Tristel were up 2.2% at 509.00p in London on Monday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
12 Oct 2015 09:47

Infection Control Firm Tristel Multiples Dividend As Profit Rises

Read more
12 Oct 2015 05:47

GET READY: Jupiter Fund Management At 0700 BST

Read more
5 Oct 2015 14:59

Earnings, Trading Statements Calendar - Week Ahead

Read more
18 Jun 2015 11:22

LONDON MIDDAY BRIEFING: Eyes Turn To Latest Greek Crisis Meeting

Read more
18 Jun 2015 10:38

WINNERS & LOSERS: Fresnillo, Randgold Resources Up As Gold Price Rises

Read more
18 Jun 2015 07:40

Tristel Shares Rise As It Reveals 3 Pence Special Dividend

Read more
21 May 2015 11:19

LONDON MIDDAY BRIEFING: Royal Mail Outlook Causes Concerns

Read more
21 May 2015 10:45

WINNERS & LOSERS: Miners Boosted By Chinese Stimulus Hopes

Read more
21 May 2015 07:39

Tristel Upgrades Profit Guidance As It Trades Ahead Of Expectations

Read more
25 Feb 2015 08:41

Tristel Raises Dividend 63% After Strong First-Half Profit Rise

Read more
11 Nov 2014 09:57

Tristel Says Another Study Has Shown Benefits Of Its Wipes Study

Read more
4 Nov 2014 15:16

Tristel chairman Soler trims stake

The chairman of hospital infection control experts Tristel sold a small chunk of his shares in the company late on Monday. Francisco Soler sold 250,000 shares in the dividend-paying company at a price of 75p per share on 31 October and on 3 November 2014 sold 100,000 more at the same price to gross

Read more
3 Nov 2014 18:08

DIRECTOR DEALINGS: Tristel Non-Executive Chairman Sells Shares

Read more
13 Oct 2014 14:46

Tristel boosts full-year profit after restructuring

Tristel, a manufacturer of infection prevention and contamination control products, saw profit for the year to end of June rise after undertaking a set of restructuring measures. An 18-month restructuring plan, the creation of new products and investment in the disinfection market led the firm to be

Read more
13 Oct 2014 09:23

Tristel Quadruples Dividend As It Swings To Profit On Restructuring

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.